Thiols of cysteine residues in proteins are common targets of intracellular oxidation. The deprotonated thiolate anion of cysteine is the reactive group, and this is the predominant form at physiological or higher pH 1 . In reacting with cysteine (or other -SH bearing compounds), two-electron oxidants, such as the reactive oxygen species (ROS) and second messenger hydrogen peroxide (H 2 O 2 ), generate a sulfenic acid (SOH) derivative as their initial oxidation product. In the presence of available proximal thiol groups, SOH can form intra-or inter-molecular disulfide bonds, or mixed disulfides with glutathione (GSH) 2 or cysteine 3, 4 . SOH can also react with vicinal nitrogens, for example, in protein tyrosine phosphatases 5, 6 , to form sulfenamides. In the presence of excess oxidants, SOH can be irreversibly oxidized to sulfinic (SO 2 H) or sulfonic (SO 3 H) acid 7, 8 . In addition, both thiols in proteins and low-molecular-weight thiols, including GSH, cysteine and homocysteine, can undergo S-nitrosylation (SNO) mediated by nitric oxide and its metabolites (including reactive nitrogen species (RNS) 9 .
The OxICAT approach In the OxICAT methodology, cysteines that are reduced in the sample at the beginning of the procedure are labeled with light ICAT, whereas, upon reduction, newly appearing reduced cysteines are labeled with heavy ICAT. This strategy has successfully been applied to detect cysteine oxidations in Escherichia coli 23 , yeast 39 and Caenorhabditis elegans 40, 41 . However, as ~90% of intracellular cysteines are in their reduced state 37 , for most of the cysteinecontaining peptides there is a big disproportion between the relative abundances of the oxidized versus the reduced forms of the same peptides. Nevertheless, to be quantified, both forms of the peptide have to be enriched and then their relative abundances have to be compared, which in most of the cases will differ by several orders of magnitude. To allow for a comprehensive analysis, extensive fractionation is required (up to 192 LC fractions) 23, [39] [40] [41] . Another pitfall of this methodology is the large amounts of ICAT reagents required to detect not only oxidized but also reduced thiols in each biological sample, which increases the price of the procedure.
Our ICAT-based comparative cysteine oxidation protocol
An alternative approach is to label reduced or oxidized thiols of two different samples and compare them at once. Here we describe the use of ICAT labeling to compare the reversibly oxidized thiolproteome of two samples at once (Fig. 1) . This approach has been successfully applied to detect reversible cysteine oxidations in the yeast Schizosaccharomyces pombe upon different genetic and environmental conditions. Thus, we have used it to compare, pairwise, the thiol proteomes of wild-type cells treated or not treated with H 2 O 2 (ref. 37) , or those of wild-type cells versus mutants with defects in the Trx system 38 . It is worth mentioning that this protocol should be easily optimized for studying the thiol proteomes of other cell types.
Reduced thiols are initially blocked with IAM, which is an inexpensive reagent that will titrate the majority of reduced intracellular thiols, which are the majority of thiols in a given proteome (>90-95%; ref. 37) . After reduction of reversible oxidized thiols, newly appearing thiols are labeled in one of the samples with the light ICAT reagent and in the other one with the heavy ICAT reagent. Upon labeling, the two samples are mixed in equal ratios, trypsinized, affinity-purified and analyzed by LC-MS/MS. For each peptide, a ratio of cysteine oxidation (ICAT ratio) is obtained by comparing the abundance of a particular peptide in one sample with the levels of the same peptide in the other sample. In this case, as only those peptides containing reversible oxidized thiols in both samples are labeled with ICAT reagents, the amount of cysteines labeled with either ICAT reagent is approximately of the same order of magnitude, thus providing a sample with a lower level of complexity. Thus, sample fractionation is not required, which accelerates and simplifies the whole process, including data analysis. To distinguish between changes in protein expression versus changes in the redox state of a particular cysteine, we propose to include protein quantification of non-enriched peptides in our protocol. MS-based relative protein quantification can be carried out by either label-free quantification or by using a stable isotope-based strategy (for a review, see ref. 42) . In this protocol, we suggest stable isotope-based relative protein quantification using dimethyl labeling, as described by Boersema et al. 43 , because this technique is inexpensive, simple and robust, and it provides workflows comparable to those of the ICAT-based quantification. Because of the expected high complexity of non-enriched samples, we suggest fractionation by, e.g., micro anion exchange, as described by Wisniewski et al. 44 . It is worth mentioning that, alternatively to dimethyl labeling, other stable isotope-based strategies such as tandem mass tags (TMT) or isobaric tags for relative and absolute quantification (iTRAQ) can be used for relative protein quantification. Thus, by combining ICAT labeling with dimethyl labeling, we are able to obtain a more complete picture at a proteomic level of relative reversible cysteine oxidations in two samples to be compared, taking into account changes in the steady-state amounts of individual proteins. It is worth mentioning that our method does not provide information about the percentage of oxidation for a particular protein within each biological sample; to overcome this limitation, we previously proposed a method for validating the ICAT results, which can also be used to quantify the amount of oxidation for individual oxidized proteins, on the basis of the in-parallel labeling for each sample of reduced and oxidized thiols with a biotin-linked reversible alkylating agent as well as the subsequent release of enriched proteins from streptavidin-Sepharose beads for western blot analysis with specific antibodies 37 . Table 1 contains a brief description of the strengths and weaknesses of the different methodologies mentioned here weighed against our ICAT-based proposed method for studying reversible thiol oxidations. It is worth mentioning that although the reviewing process of this article was in progress, Smith and Qian 45 have reported another gel-free methodology based on the direct binding of originally oxidized cysteines to a thiol-binding resin. We believe that we provide to the community a robust methodology to quantify cysteine oxidations with high sensitivity and quantitative accuracy in two samples to be compared at once.
Experimental design
The presented gel-free, ICAT-adapted biotin switch assay has been developed to identify, compare and quantify reversible cysteine oxidations in two biological samples at the peptide level. This is an easy-to-follow protocol that overcomes most limitations of previous methodologies, such as the gel-based approaches or the OxICAT technique.
For best results, attention should be paid to the following key points:
Trapping the redox state of the thiols. Owing to the highly reactive nature of the thiolate anion, a major challenge when studying reversible cysteine oxidations is to obtain a snapshot of the in vivo cysteine redox status (for a review, see ref. 46 ). Cell-permeable alkylating agents have been often used to trap the redox state of thiols during sample preparation, but incomplete thiol alkylation in vivo has been demonstrated both for N-ethylmaleimide 22, 47 and IAM 48 . In our approach, trichloroacetic acid (TCA) is added to the cell medium instead. TCA not only rapidly protonates all redox-active thiolate anions by shifting the pH below their pK a , but also stops thiol-disulfide exchanges by precipitating and denaturing proteins 23, 49 . This will cause a decrease of at least tenfold in the thiol-disulfide shuffling reaction rates per each pH unit below the cysteine pK a value. Addition of TCA to the cell medium before cell collection is especially relevant to obtain a real 'snapshot' of transient thiol proteomes, such as those arising upon environmental H 2 O 2 treatments. In a later step (see 'Blocking reduced thiols' below), IAM is used to irreversibly modify reduced thiols. As a control to demonstrate the importance of using this combined strategy (TCA followed by alkylating agent) as opposed to the use of only an alkylating agent, we analyzed the redox state of Pap1, an S. pombe transcription factor whose cysteine residues are transiently oxidized upon H 2 O 2 treatments. As shown in Supplementary Figure 1 , the full in vivo transition from a reduced to an oxidized state in Pap1 is only preserved when the combined strategy is applied. As some reports indicate that TCA precipitations may be slightly inefficient and introduce variability in the precipitated protein amounts [50] [51] [52] , we strongly suggest Figure 1 | Schematic representation of the gel-free strategy to identify and quantify oxidized cysteines by using the ICAT technology on a proteomic scale. TCA extracts are prepared from two conditions to be compared (conditions 1 and 2). Thiols (-SH) in the extracts are alkylated with IAM. Upon reduction of reversibly oxidized thiols (-SSR) with TCEP, the resulting thiols (-SH) are alkylated with either light (B-12 C-IAM, condition 1) or heavy (B-13 C-IAM, condition 2) ICAT reagents. Labeled protein extracts (pro. ext.) are then mixed and digested with trypsin. ICAT-labeled peptides are affinitypurified with streptavidin beads, fractionated by LC and analyzed by LC-MS/MS. To quantify individual proteins by dimethyl labeling, small fractions of protein extracts are digested with trypsin, and the resulting peptides are labeled at their amino groups (-NH 2 ) with medium (D-CDO, condition 1) or heavy (D-13 CDO, condition 2) formaldehyde. The resulting peptides are mixed, fractionated by liquid chromatography and analyzed by LC-MS/MS. 
performing steps involving TCA precipitation carefully. Protein amounts may be checked after each precipitation step to follow up on uncontrolled losses.
Pilot experiment using 1D electrophoresis. Before using the ICAT-based proteomic methodology to interrogate different oxi-proteomes, we strongly encourage the fluorescent labeling of oxidized thiols in TCA extracts, followed by fluorescent scanning of 1D gels as a pilot experiment (see ANTICIPATED RESULTS and Fig. 2a ) 37 .
Amount of protein required for analysis. The starting protein amount in each sample is recommended to be ~2 mg. With this amount of protein, a single vial of ICAT reagent per sample will be Blocking reduced thiols. We recommend excess IAM to initially block all reduced thiols in extracts (i.e., for 2 mg of protein, we use 100 mM IAM in a volume of 0.5 ml) instead of other alkylating agents such as N-ethylmaleimide. In general, alkylation rates of N-ethylmaleimide are faster than those of IAM, especially at low pH 46, 48 . The reason for choosing IAM is that not only reduced thiols but also other sites prone to unspecific alkylation will be blocked with IAM (IAM can also alkylate amines from lysines and N-terminal positions 53 , thioethers in methionines 54, 55 , imidazoles in histidines 56 and carboxylates from aspartate and glutamate) 53 . ICAT reagents are IAM derivatives, and they are expected to have similar unspecific alkylation properties to those described for IAM. By using IAM as a first blocking reagent, we ensure only specific cysteine labeling of newly reduced thiols with the IAM-based ICAT reagents in the second alkylation step.
Use of buffers.
TCA is extensively used throughout the whole protocol, either to initially freeze the in vivo thiol oxidation status or for protein precipitation between labeling and reducing steps. For this reason, we strongly recommend buffering the alkylating and the reducing steps with 200 mM Tris-HCl (pH 8.5).
The pH should be checked in each step with standard pH strips. A denaturing buffer is also recommended, 6 M urea, to maximize the accessibility to the alkylating agent and to minimize artifactual alkylations due to oxidation being faster than the alkylation step.
Nonspecific reduction of reversible cysteine oxidations. After reduced thiol titration with IAM, we propose the use of TCEP to nonspecifically reduce all reversible cysteine oxidations.
Determining protein concentration. Upon reduction with TCEP, and before protein precipitation with TCA, protein concentration of the samples to be compared should be determined by Bradford assay and then equalized between samples. Hereafter, remove 100 µg of each sample for dimethyl-based relative protein expression analysis ( Fig. 1 ). The remaining samples are then TCA-precipitated before labeling with the ICAT reagents.
Buffer composition for trypsin digestion. As the ICAT buffer contains 6 M urea, light and heavy ICAT reactions must be diluted to <1 M urea in 10 mM CaCl 2 for digestion with the trypsin provided in the ICAT kit (AB Sciex) after mixing for good trypsin digestion.
LC-MS/MS analysis of mixed ICAT samples and biological replicates.
If the sample amount permits, subject the sample to multiple LC-MS/MS analyses. Increasing the number of LC-MS/ MS analyses often increases the number of matched peptides and, of particular importance for the ICAT samples in which many oxidized thiols only will exist in one particular peptide, it allows for multiple measurements of the same peptide. An alternative would be to use multiple proteases. This can generate different peptides containing the same cysteine and/or peptides containing oxidized thiols that are not accessible by trypsin. If biological or/and technical replicates are carried out, we recommend switching the light and heavy ICAT reagents (label swap) 57 . With regard to the number of biological replicates, we suggest using two or three replicates per condition, one of them with label swapping.
Normalizing the cysteine oxidation/protein ratios
Normalize individual ICAT and dimethyl ratios for each condition by dividing each of those ratios by the median value of all dimethyl ratios obtained for the same condition (Fig. 2b ). This will correct the bias due to different protein loading, errors in measuring protein concentrations or sample losses. Figure 2 . EQUIPMENT SETUP Liquid chromatography With regard to LC, it is important to distinguish the two types of samples to be analyzed. The ICAT-labeled enriched samples are expected to be of lower complexity, and therefore they do not require extended long gradients. The dimethyl-labeled sample complexity is high, and it will benefit from longer (3-h) gradients and/or orthogonal to reversedphase prefractionation before LC-MS/MS analysis. As the quantification of both ICAT-and dimethyl-labeled samples is based on MS rather than MS/MS spectra, the latter being the case for isobaric tags exemplified by iTRAQ and TMT, it is important that enough MS spectra be generated per peptide to obtain sound quantification. Applied gradients should therefore not be too steep (suggestion for gradients and MS parameters are available in Supplementary Data 1 and 2) . We have not observed large retention time shifts between the same peptide modified with ICAT and modified with carbamidomethyl (Supplementary Data 3) and the resolving gradients final percent of organic (buffer B) is therefore not different between the two types of samples to be analyzed. Mass spectrometers As for most stable isotope-based quantification experiments, the use of a mass spectrometer that is capable of measuring precursor masses with high resolution and high mass accuracy is beneficial. For this protocol, we recommend an Orbitrap mass spectrometer (Thermo Scientific) solely because the data format from this type of instrument feeds well into  crItIcal step For good performance in all the following steps, the maximum amount of cells to be collected in a 1.5-ml centrifuge tube should correspond to 50 ml of culture at OD 600 ~0.5 (5 × 10 8 cells).  pause poInt Pellets can be stored at −80 °C at least for 2 weeks.
3| Optional monitoring step. We propose checking reversible thiol oxidation by 1D electrophoresis before continuing with the protocol with the whole protocol. This can be done with the amount of pellet equivalent to 10 ml of culture. In ref. 37 , there is a full description of the recommended protocol. The remaining sample can remain at −80 °C until it is further processed. To generate control samples with severe thiol oxidation, some treatments that we usually apply to yeast cells are 5 mM H 2 O 2 or 1 mM diamide for 1-5 min, although these control treatments may change depending on the cell type.
4|
Resuspend the pellets in 250 µl of 12.5% (wt/vol) TCA. Fill with glass beads up to 85-90% of the volume to allow proper disruption.
5|
To disrupt the cells, vortex the suspension at maximum speed for 5 min in a vortex for microcentrifuge tubes.  crItIcal step To avoid overheating of the lysates, keep the vortex in a cold chamber at 4 °C.
6|
Use a flame-heated needle (0.6 × 25 mm) to pierce two holes, one at the bottom and the other at the top of each 1.5-ml microcentrifuge tube, and then place each tube on the top of another 1.5-ml tube. Centrifuge the tubes to separate the lysate from the beads at 850g for 30 s at 4 °C.
7|
Centrifuge the cell lysates at 20,000g for 20 min at 4 °C.
8|
Remove the supernatants and wash the pellets with 1 ml of chilled acetone (−20 °C), with the help of the blunt side of a plastic inoculation loop. Centrifuge the pellets at 20,000g for 5 min at 4 °C.
9|
Remove the supernatants and repeat the previous step.
10|
Remove the supernatants and dry the pellets with the help of a vacuum concentrator, by centrifuging for 2 min at 37 °C. Alternatively, the pellets can be dried by placing them for ~8 min in an oven preheated to 55 °C. 19| Withdraw 100 µg of each condition for dimethyl labeling (this amount of protein is contained in ~16 µl of volume) (see Step 38) . 
22|
23|
Remove the supernatants and dry the pellets with the help of a vacuum concentrator, as in Step 10.
Icat labeling of reversibly oxidized cysteines • tIMInG 140 min 24|
Resuspend the pellet belonging to one condition with 1 ml of heavy alkylating buffer, and the pellet belonging to the other condition with 1 ml of light alkylating buffer with the help of the blunt side of a plastic inoculation loop. Thirty seconds of sonication at the maximum power in a water bath sonicator may help resuspend pellets. Incubate the mixtures for 2 h at 37 °C in the dark and with shaking.
? troublesHootInG 25| Stop the ICAT labeling reaction by adding 1.75 µl of 1 M DTT (tenfold molar excess over ICAT reagent). Allow the reaction to take place by incubation at room temperature for 5 min.
26| Optional monitoring step. We recommend checking ICAT labeling prior to digestion. Separate a fraction (2.5 µg) of the ICAT-labeled protein samples by SDS-PAGE followed by detection with standard anti-biotin or streptavidin-conjugated antibodies.
trypsin digestion • tIMInG 16 h 27| Pool light and heavy reactions in a 15-ml tube. Dilute them by adding 10 ml of 10 mM CaCl 2 to reduce the urea concentration to 1 M. Add 100 µg of TPCK-treated trypsin (1:40 ratio) and allow the digestion to take place for 16 h at 37 °C with mild agitation and protected from light.
28| Monitoring step (optional).
Appropriate trypsin digestion can be followed by processing a tiny fraction of the sample by MS and by checking peptide missed cleavages and ion charges. ? troublesHootInG peptide desalting • tIMInG 30 min 29| Peptides must be desalted to remove salts and urea from the digestion buffer. We use Oasis HLB Plus LP extraction cartridges, which are appropriate for peptide amounts >10 µg.
30|
Wash and condition the cartridge with 5 ml of 100% ACN.
31|
Equilibrate with 5 ml of 5% (vol/vol) formic acid.
32|
Acidify the sample to pH 2-3 with formic acid, and load it into the cartridge.
33|
Wash it with 5 ml of 5% (vol/vol) formic acid.
34|
Elute it with 5 ml of 70% ACN/5% formic acid (vol/vol). Evaporate the sample to dryness with a vacuum concentrator for 1.5-ml microcentrifuge tubes (4-5 h).
chromatography, affinity purification and biotin cleavage • tIMInG 7 h 35| Perform cation exchange chromatography, affinity purification and biotin cleavage exactly according to the ICAT kit manufacturer's instructions.
36|
Resuspend the dried pellets in 4 ml of cation exchange load buffer from the ICAT kit, and then further process them according to the manufacturer's instructions up to finishing the section of cleaving the ICAT reagent-labeled peptides. At this point, the sample is a dry pellet that is ready to be separated and analyzed by LC-MS/MS.
lc-Ms/Ms of Icat-labeled peptides and data analysis • tIMInG 2 d 37|
Resuspend the dry pellet in 15 µl of loading solvent and inject the sample onto the LC-MS/MS system. Analyze the samples by LC-MS/MS in three runs of 5 µl each. See Equipment Setup for details. In
Step 19, 100 µg of total protein extract for each condition (in our case, 100 µg of protein was obtained in a volume of 16 µl) is withdrawn for dimethyl labeling. We follow the in-solution protocol for dimethyl labeling described in Boersema et al. 43 , with some modifications meant to allow subsequent sample fractionation to reach higher proteome coverage after LC-MS/MS. 
41|
After protein digestion, desalt 25 µg (36 µl) of the sample with two disks of Empore C18. Upon cleaning, dry the sample by vacuum centrifugation.
Isotopic labeling • tIMInG 80 min 42| Reconstitute the digested samples in 100 µl of 25 mM TEAB.  crItIcal step 25 mM TEAB is used instead of 100 mM TEAB 43 when performing strong anion exchange after labeling. Too high a salt percentage interferes with peptide sticking to the anion exchange material.
Box 1 | Data analysis • tIMInG 1-2 d
This protocol includes two types of relative quantification: a protein-centric comparison of the two samples of dimethyl-labeled peptides and a peptide-centric comparison of ICAT-labeled peptides. Modifications used for the MS/MS search are listed in supplementary Data 7. The protein-centric comparison of the two samples is described in great detail by Boersema et al. 43 , and most quantification software will handle this analysis well. For the peptide-centric quantification analysis, it is preferred to use software capable of quantifying peptides with multiple cysteine residues differing in labeling (e.g., one cysteine is carbamidomethylated, whereas another is ICAT-labeled within the same peptide). Some quantification software (e.g., ProteomeDiscoverer v. 1.4. Thermo Scientific) will disqualify such peptides as 'incomplete labeled' and no quantitative measures will be available for this group of peptides. MaxQuant v. 1.3.0.5 (http://maxquant.org) 58 can handle this group of differentially labeled cysteines. For the data set shown here, ~10% of all peptides contained two or more cysteines. In addition, the MaxQuant platform allows you to define multiple groups of search and quantification parameters, making it possible to combine the protein-centric and the peptide-centric data in one analysis. Benefits to this strategy include (i) consistent gene symbols and protein names between the protein-centric and the peptide-centric correlations, and (ii) the combined data set is used to calculate false discovery rate. A limitation to MaxQuant v.1.3.0.5 is that this platform is limited to Thermo Scientific's .RAW data format. An alternative software strategy that allows quantification of peptides containing multiple and differentially labeled cysteines is the combination of MSQuant (http://msquant.alwaysdata.net/) 61, 62 with MASCOT (Matrixscience), as previously described 37 . The objective of this procedure is not to be a manual for MaxQuant v. 1.3.0.5, but to list important parameters; supplementary Data 1-10 also contains descriptive figures. 1. Load .RAW files from measurements of the ICAT and dimethyl samples. 2. Define .RAW files appropriately. Use different 'Parameter groups' for the ICAT and the dimethyl data files (supplementary Data 8 and 9). 3. Create an experimental design ('Exp. Design'). Once it is created, this file (experimentalDesignTemplate.txt) can be found in folder 'Combined' (found in the folder containing the RAW data). Use a text editor to describe the experiment and save this file (supplementary Data 8). 4. In the tab 'Group specific parameters,' define the search and quantification parameters for the dimethyl experiment ('Group 1') and the ICAT experiment ('Group 2'). For both experiments, it is important that carbamylation of cysteines be chosen as a variable modification (supplementary Data 8). 5. In the 'MS/MS and sequences' tab, it is important that carbamylation of cysteines is not chosen as a fixed modification (supplementary Data 8). 6. In the tab 'Quantification & identification,' it is important to include carbamylation of cysteines to the modification box 'Use only unmodified peptides and…' under 'Protein quantification' . 7. Select the 'experimentalDesignTemplate.txt' file describing the experimental relationship between the generated .RAW files (supplementary Data 8). 43| Continue the protocol as described in Boersema et al. 43 , in-solution stable isotope dimethyl labeling. ? troublesHootInG 44| At this stage, each sample is mixed with the dimethyl labeling reagents in a final volume of 124 µl. Add 8 µl of 1% (vol/vol) ammonia solution to each sample.  crItIcal step The sample is not acidified as in Boersema et al. 43 , but further ammonia solution is added to facilitate the anion exchange fractionation before LC-MS/MS.
45|
Mix the two differentially labeled samples.
Fractionation of dimethyl-labeled peptides by strong anion exchange • tIMInG 2 h 46| After mixing the samples and before LC-MS/MS analysis, dimethyl-labeled peptides should be separated into six pH fractions (11, 8, 6, 5, 4 and 3) according to the protocol described in ref. 44 .  crItIcal step Fractionation by strong anion exchange is recommended to enhance proteome coverage after LC-MS/MS analysis, but it is also required for efficient removal of SDS. 52| Analyze the data obtained by using box 1 as a guide. Analysis of the dimethyl-labeled peptides is described in detail in the protocol by Boersema et al. 43 Our aim was to interrogate thiol homeostasis by providing an extracellular source of oxidants and by genetically compromising the Trx system. As indicated in the Experimental design section, before performing this ICAT-based proteomic methodology to compare two cysteine-oxidized proteomes, we strongly encourage researchers to perform as a pilot experiment the fluorescent labeling of oxidized thiols in TCA extracts followed by fluorescent scanning of 1D gels, as previously published 37 .
As shown in Figure 2a by using this strategy, all three biological condition0s triggered general thiol oxidation but to different extents, with cells lacking Trr1 clearly displaying increased thiol oxidation. According to the procedure described above and summarized in Figure 1 , extracts from wild-type untreated cells (condition 1) are compared with extracts from another environmental biological sample (condition 2). In this case, condition 2 was either an environmental (treatment of wild-type cells with mild concentrations of H 2 O 2 ) or a genetic intervention (cells lacking Trx1 or Trr1).
To identify of ICAT-labeled peptides in the experiment corresponding to Figure 2 , two biological replicates, with two or three technical replicates each, were performed for all four tested conditions (extracts from wild-type cells, from wild-type cells treated with H 2 O 2 and from S. pombe ∆trx1 and ∆trr1 cells). Technical replicates increased peptide identifications ~50%, resulting in an average of 500 ICAT-labeled peptides detected for any studied condition. In terms of sensitivity, this approach allows the identification and quantification of proteins expressed at low levels, exemplified by the S. pombe transcription factor Pap1 (supplementary tables 1-3) .
One biological replicate of each ICAT pair was subjected to protein quantification by dimethyl labeling. Three technical replicates and sample fractionation into six pH fractions before analysis by LC-MS/MS were performed for this approach. This resulted in the identification and quantification of more than one peptide for >75% of the dimethyl-labeled proteins for any condition. An average dimethyl ratio was calculated for each protein by using the individual ratios of all peptides belonging to the same protein. 72-78% of the ICAT-labeled peptides enriched in the affinity purification step belonged to proteins whose relative concentrations were determined by dimethyl labeling. If we look at the whole set of dimethyl-labeled proteins, we were able to quantify 19-30% of the fission yeast proteome, depending on the studied condition. A larger proteome coverage can easily be achieved by increasing the number of fractions per sample before LC-MS/MS analysis 44 .
To correct possible bias due to differential protein loading between ICAT pairs, we used the overall median value of all dimethyl ratios for a specific condition to normalize both individual ICAT and dimethyl ratios obtained for the same condition. As an example, in Figure 2b , the distribution of the ICAT ratios and dimethyl ratios for one experimental condition before (left) and after (right) data normalization is represented.
Only peptides present in at least two biological replicates were used to finally describe those proteins with increased levels of reversible oxidized thiols in each experimental setting, when compared with the wild-type untreated condition. Figure 2c shows an example of the overlapping areas of the ICAT-labeled peptides between the two biological replicates for extracts from cells lacking Trx1 versus extracts from wild-type untreated cells. Taking into account those peptides with a ratio of cysteine oxidation versus protein levels over 1.5-fold, we obtained percentages of reversible oxidation that go up to 8% upon H 2 O 2 treatment, up to 30% in cells lacking Trr1 and close to 1.3% in the absence of Trx1 (Fig. 2c) . These proteomicbased peptide oxidation percentages show very good agreement with those levels of reversible oxidized proteins, as determined by 1D electrophoresis (Fig. 2a) . When a strain or an environmental condition has low levels of reversible oxidized thiols, only those that are truly oxidized appear with high ICAT ratios in the different biological replicates when compared with a wild-type strain or situation (this would be the case of the ∆trx1 strain when compared with a wild-type strain); however, the technique is strong enough to detect a massive number of peptides with high ICAT ratios when the strain or environmental condition generates high levels of reversible oxidized thiols (that is the case for strains lacking Trx reductase,
